Edition:
United States

People: Stryker Corp (SYK.N)

SYK.N on New York Stock Exchange

138.37USD
10:39am EDT
Change (% chg)

$-7.14 (-4.91%)
Prev Close
$145.51
Open
$141.11
Day's High
$141.30
Day's Low
$137.70
Volume
205,765
Avg. Vol
324,426
52-wk High
$148.83
52-wk Low
$106.48

Doliveux, Roch 

Dr. Roch Doliveux, DVM, is Independent Director of Stryker Corp., since June 21, 2010. He is a Former Chief Executive Officer and Chairman of the Executive Committee of UCB S.A., a global biopharmaceutical company, from 2005 through 2014. Prior thereto, he was Chief Executive Officer of Pierre Fabre Pharmaceuticals and President of Schering-Plough International, a subsidiary of Schering-Plough Corporation, now Merck and Co. He is Chairman of the GLG Healthcare Institute, a community of senior executives for experience sharing and learning and Vice Chairman of the Board of the Vlerick Business School, a top-100 business school in the world based in Belgium.

Basic Compensation

Total Annual Compensation, USD 118,152
Restricted Stock Awards, USD 88,380
Long-Term Incentive Plans, USD --
All Other, USD 80,982
Fiscal Year Total, USD 287,514

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kevin Lobo

12,797,400

Glenn Boehnlein

2,986,300

Lonny Carpenter

3,458,690

David Floyd

4,049,580

Graham Mclean

--

Timothy Scannell

4,770,130
As Of  30 Dec 2016